Skip to Content

M A11 (Alendronate Sodium 35 mg)

Pill with imprint M A11 is White, Capsule-shape and has been identified as Alendronate Sodium 35 mg. It is supplied by Mylan Pharmaceuticals Inc..

Alendronate is used in the treatment of prevention of osteoporosis; osteoporosis; paget's disease and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Alendronate 35 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M A11

Alendronate sodium 35 mg M A11
Alendronate sodium 35 mg M A11
Alendronate sodium 35 mg M A11

Alendronate Sodium

Imprint
M A11
Strength
35 mg
Color
White
Size
10.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Bisphosphonates
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-3568
Inactive Ingredients
silicon dioxide, magnesium stearate, mannitol, microcrystalline cellulose, sodium lauryl sulfate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "M A11"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.